TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling.
Related Research units
Abstract
TMPRSS2-ERG gene fusions occur in about 50% of all prostate cancer cases and represent promising markers for molecular subtyping. Although TMPRSS2-ERG fusion seems to be a critical event in prostate cancer, the precise functional role in cancer development and progression is still unclear.
Bibliographical data
| Original language | English |
|---|---|
| ISSN | 1471-2407 |
| DOIs | |
| Publication status | Published - 2011 |
| pubmed | 22142399 |
|---|
